That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Anthropic says AI could soon improve without human intervention Development pause will allow society to deal with AI's implications, startup says Previous attempts to halt AI progress have not been ...

RSI is also defined as an “AI system capable of fully autonomously designing and developing its own successor,” per Anthropic’s blog post. “We are not there yet, and recursive self-improvement is not ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

[!INCLUDE SQL Server Azure SQL Database Azure SQL Managed Instance] Both DML and DDL triggers are nested when a trigger performs an action that initiates another trigger. These actions can initiate ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence, a startup founded by former leaders from Meta AI, Google DeepMind, OpenAI, and Salesforce AI, has emerged from stealth with $650 million in funding at a $4.65 billion ...

It’s time to switch to a new development tool for SQL Server and Azure SQL. Here’s how to get started with the MSSQL extension for Visual Studio Code. Microsoft recently ended support for Azure Data ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...